WAYFIND-R

Name No. For Patients with Purpose
WAYFIND-R 21-30

With a solid tumour and whose tumour has been profiled with a next-generation sequencing (NGS) test.

WAYFIND-R aims to enable collaborations and to provide meaningful insights and high-quality evidence to enhance our understanding of precision oncology and ultimately transform the lives of people with cancer.


SABR COMET 3

Name No. For Patients with Purpose
SABR COMET 3 CTRIAL-IE 19-21

Oligometastatic disease who have one controlled primary solid tumour and 1-3 current metastatic lesions, and a maximum of 8 lifetime metastatic lesions

The purpose of the study is to assess the impact of Stereotactic Ablative Radiotherapy (SABR), compared to standard of care (SOC) treatment, on overall survival, oncologic outcomes, and quality of life in patients with 1-3 current metastatic lesions.


CUPISCO

Name No. For Patients with Purpose
CUPISCO CTRIAL-IE 18-29

Multiple types of cancer.

This study will evaluate the efficacy and safety of targeted therapy or cancer immunotherapy guided by genomic profiling versus platinum-based chemotherapy


MK7339-002 / LYNK-002

Name No. For Patients with Purpose
MK7339-002 / LYNK-002 CTRIAL-IE 19-27

Multiple types of cancer

This study will evaluate the efficacy and safety of olaparib monotherapy in participants with multiple types of advanced cancer (unresectable and/or metastatic).


LOXO 101

Name No. For Patients with Purpose
LOXO 101 15-42

NTRK fusion-positive breast cancer

The purpose of the trial is to determine the overall response rate following treatment with LOXO-101.